Sona Nanotech Stock Today
| SNANF Stock | USD 0.19 0.01 5.00% |
Performance0 of 100
| Odds Of DistressOver 88
|
Sona Nanotech is trading at 0.19 as of the 1st of December 2024. This is a 5 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.19. Sona Nanotech has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Sona Nanotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company has 68.99 M outstanding shares. More on Sona Nanotech
Moving together with Sona OTC Stock
Moving against Sona OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sona OTC Stock Highlights
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
Sona Nanotech [SNANF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sona Nanotech's market, we take the total number of its shares issued and multiply it by Sona Nanotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sona Nanotech classifies itself under Healthcare sector and is part of Diagnostics & Research industry. The entity has 68.99 M outstanding shares.
Sona Nanotech has accumulated about 402.77 K in cash with (3.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Sona Nanotech Probability Of Bankruptcy
Ownership AllocationSona Nanotech shows a total of 68.99 Million outstanding shares. Sona Nanotech has 13.6 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sona Ownership Details
Sona Nanotech Risk Profiles
| Mean Deviation | 2.61 | |||
| Standard Deviation | 5.44 | |||
| Variance | 29.57 | |||
| Risk Adjusted Performance | 0.0078 |
Sona Stock Against Markets
Picking the right benchmark for Sona Nanotech otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sona Nanotech otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sona Nanotech is critical whether you are bullish or bearish towards Sona Nanotech at a given time. Please also check how Sona Nanotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sona Nanotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Sona Nanotech Corporate Management
Elected by the shareholders, the Sona Nanotech's board of directors comprises two types of representatives: Sona Nanotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sona. The board's role is to monitor Sona Nanotech's management team and ensure that shareholders' interests are well served. Sona Nanotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sona Nanotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Regan | Chief Officer | Profile | |
| Darren Rowles | Pres Officer | Profile | |
| Robert Randall | CFO Sec | Profile | |
| Gerrard Marangoni | CoFounder Board | Profile | |
| Kulbir Singh | CoFounder RD | Profile | |
| Mike McAlduff | Director Founder | Profile |
Other Information on Investing in Sona OTC Stock
Sona Nanotech financial ratios help investors to determine whether Sona OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sona with respect to the benefits of owning Sona Nanotech security.